Regardless of its established role in androgen regulation and androgen signaling in prostate cancer, our findings suggest that tumors harboring the adrenal-permissive HSD3B1 exhibit profound differences in biological pathways. This evidence concerns the gene HSD3B1 and Familial prostate cancer.